Evidence map›Paper›PMID 37762647›Full record

ArticleInternational journal of molecular sciences2023

Limited Cheese Intake Paradigm Replaces Patterns of Behavioral Disorders in Experimental PTSD: Focus on Resveratrol Supplementation.

Vadim E Tseilikman, Vladislav A Shatilov, Maxim S Zhukov, Irina A Buksha, Alexandr E Epitashvily, Ilya A Lipatov, Maxim R Aristov, Alexandr G Koshelev, Marina N Karpenko, Dmitrii S Traktirov and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

Vadim E TseilikmanScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.
Vladislav A ShatilovScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.
Maxim S ZhukovScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.
Irina A BukshaFaculty of Fundamental Medicine, Chelyabinsk State University, 454001 Chelyabinsk, Russia.
Alexandr E EpitashvilyFaculty of Fundamental Medicine, Chelyabinsk State University, 454001 Chelyabinsk, Russia.
Ilya A LipatovFaculty of Fundamental Medicine, Chelyabinsk State University, 454001 Chelyabinsk, Russia.
Maxim R AristovScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.
Alexandr G KoshelevFaculty of Fundamental Medicine, Chelyabinsk State University, 454001 Chelyabinsk, Russia.
Marina N KarpenkoPavlov Department of Physiology, Institute of Experimental Medicine, 197376 Saint Petersburg, Russia.
Dmitrii S TraktirovPavlov Department of Physiology, Institute of Experimental Medicine, 197376 Saint Petersburg, Russia.
Viktoriya A MaistrenkoScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.ORCID 0000-0001-7004-7873
Mustapha KamelScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.
Alexey V BuhlerScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.
Elena G KovalevaResearch, Educational and Innovative Center of Chemical and Pharmaceutical Technologies Chemical Technology Institute, Ural Federal University Named after the First President of Russia B.N. Yeltsin, 620002 Ekaterinburg, Russia.
Tatyana S KalininaInstitute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, 630090 Novosibirsk, Russia.
Anton A PashkovFederal Neurosurgical Center, 630048 Novosibirsk, Russia.
Vadim V Kon'kovZelman Institute of Medicine and Psychology, Novosibirsk State University, 630090 Novosibirsk, Russia.
Jurica NovakDepartment of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0001-5744-6677
Olga B TseilikmanScientific and Educational Center 'Biomedical Technologies', School of Medical Biology, South Ural State University, 454080 Chelyabinsk, Russia.
South Ural State University · RUChelyabinsk State University · RUInstitute of Experimental Medicine · RUFederal Neurosurgical Center Novosibirsk · RUInstitute of Cytology and Genetics · RUNovosibirsk State University · RUUniversity of Rijeka · HRUral Federal University · RU

Funding

Russian Science Foundation 23-15-20040
6 · The paper itself

Abstract

Currently, the efficacy of drug therapy for post-traumatic stress disorder or PTSD leaves much to be desired, making nutraceutical support a promising avenue for treatment. Recent research has identified the protective effects of resveratrol in PTSD. Here, we tested the behavioral and neurobiological effects of combining cheese consumption with resveratrol supplements in an experimental PTSD model. Using the elevated plus maze test, we observed that cheese intake resulted in a shift from anxiety-like behavior to depressive behavior, evident in increased freezing acts. However, no significant changes in the anxiety index value were observed. Interestingly, supplementation with cheese and resveratrol only led to the elimination of freezing behavior in half of the PTSD rats. We further segregated the rats into two groups based on freezing behavior: Freezing

Indexed as

CheeseStress Disorders, Post-TraumaticAminesAnimalsBrain-Derived Neurotrophic FactorDietary SupplementsRatsResveratrolAminesBrain-Derived Neurotrophic FactorResveratrolanxietybrain-derived neurotrophic factordopaminefreezingmonoamines oxidize-APTSDresveratrolserotonin

Identifiers

PMID37762647
PMCPMC10532287
OpenAlexW4386879634

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.